Sidra Medicine Successfully Conducts First Clinical Trial for Pediatric Congenital Hyperinsulinism.
Doha: Sidra Medicine, a member of Qatar Foundation, has successfully conducted Qatar’s first industry-sponsored pharmaceutical trial for pediatric congenital hyperinsulinism on a young patient. The trial follows Sidra Medicine’s launch of its Clinical…